{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:08:51Z","timestamp":1790352531229,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472344"],"award-info":[{"award-number":["82472344"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102467"],"award-info":[{"award-number":["82102467"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030063"],"award-info":[{"award-number":["82030063"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013795","name":"Fujian Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jhepr.2025.101456","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T02:58:58Z","timestamp":1747969138000},"page":"101456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A novel therapy targeting the gut\u2013liver axis for chronic hepatitis B: Ursodeoxycholic acid plus Bifidobacterium"],"prefix":"10.1016","volume":"7","author":[{"given":"Zhen","family":"Xun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caorui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujue","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renquan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3058-5137","authenticated-orcid":false,"given":"Shanjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wennan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7878-3314","authenticated-orcid":false,"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9923-3212","authenticated-orcid":false,"given":"Qishui","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101456_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2468-1253(22)00386-7","article-title":"Global reporting of progress towards elimination of hepatitis B and hepatitis C","volume":"8","author":"Cui","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101456_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhepr.2025.101456_bib3","first-page":"1425","article-title":"Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)","volume":"11","author":"You","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jhepr.2025.101456_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41423-020-00601-8","article-title":"Taurocholic acid inhibits the response to interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8+ T and NK cell function","volume":"18","author":"Xun","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhepr.2025.101456_bib5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41564-019-0602-7","article-title":"The intestinal regionalization of acute norovirus infection is regulated by the microbiota via bile acid-mediated priming of type III interferon","volume":"5","author":"Grau","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jhepr.2025.101456_bib6","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1111\/j.1742-4658.2010.07695.x","article-title":"Bile acids increase hepatitis B virus gene expression and inhibit interferon-alpha activity","volume":"277","author":"Kim","year":"2010","journal-title":"FEBS J"},{"key":"10.1016\/j.jhepr.2025.101456_bib7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101456_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41586-022-05594-0","article-title":"FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2","volume":"615","author":"Brevini","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2025.101456_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhepr.2025.101456_bib10","article-title":"Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid","volume":"5","author":"Hochberg","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101456_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107396","article-title":"Ursodeoxycholic acid and cancer: from chemoprevention to chemotherapy","volume":"203","author":"Goossens","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2025.101456_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","article-title":"Gut microbiome, liver immunology, and liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhepr.2025.101456_bib13","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cell.2020.06.029","article-title":"The intestinal microbiome restricts alphavirus infection and dissemination through a bile acid-type I IFN signaling Axis","volume":"182","author":"Winkler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2025.101456_bib14","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1073\/pnas.1424775112","article-title":"Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota","volume":"112","author":"Chou","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhepr.2025.101456_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jhin.2017.04.007","article-title":"Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy","volume":"96","author":"Kang","year":"2017","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jhepr.2025.101456_bib16","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome","volume":"25","author":"Qi","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2025.101456_bib17","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/hep.29008","article-title":"Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy","volume":"65","author":"Ren","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101456_bib18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/gutjnl-2020-320786","article-title":"Targeting the gut-liver-immune axis to treat cirrhosis","volume":"70","author":"Tranah","year":"2021","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.jhepr.2025.101456_bib19","article-title":"A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH","volume":"6","author":"Gillard","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101456_bib20","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1038\/s41467-020-17183-8","article-title":"Bile acids drive the newborn\u2019s gut microbiota maturation","volume":"11","author":"van Best","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2025.101456_bib21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2025.101456_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.chom.2023.11.011","article-title":"Bifidobacterium longum promotes postoperative liver function recovery in patients with hepatocellular carcinoma","volume":"32","author":"Yu","year":"2024","journal-title":"Cell Host & Microbe"},{"key":"10.1016\/j.jhepr.2025.101456_bib23","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41423-023-01026-9","article-title":"Emerging roles of bile acids in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma","volume":"20","author":"Xun","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhepr.2025.101456_bib24","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1111\/bph.14705","article-title":"Ursodeoxycholic acid accelerates bile acid enterohepatic circulation","volume":"176","author":"Zhang","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jhepr.2025.101456_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s13167-019-00184-z","article-title":"Probiotic Lactobacillus and Bifidobacterium strains possess safety characteristics, antiviral activities and host adherence factors revealed by genome mining","volume":"10","author":"Abdelhamid","year":"2019","journal-title":"EPMA J"},{"key":"10.1016\/j.jhepr.2025.101456_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid\u2013microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101456_bib27","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","article-title":"How to achieve functional cure of HBV: stopping NUCs, adding interferon or new drug development?","volume":"76","author":"Wong","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101456_bib28","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41423-022-00848-3","article-title":"The combination of PD-1 blockade with interferon-\u03b1 has a synergistic effect on hepatocellular carcinoma","volume":"19","author":"Zhu","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhepr.2025.101456_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41564-020-00831-6","article-title":"Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice","volume":"6","author":"Lee","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jhepr.2025.101456_bib30","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1038\/s41467-022-31141-6","article-title":"Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-beta degradation","volume":"13","author":"Shen","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2025.101456_bib31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.gastro.2012.10.039","article-title":"Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice","volume":"144","author":"Li","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101456_bib32","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andr\u00e9","year":"2018","journal-title":"Cell"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592500134X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592500134X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:08:45Z","timestamp":1778904525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258955592500134X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S258955592500134X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101456","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel therapy targeting the gut\u2013liver axis for chronic hepatitis B: Ursodeoxycholic acid plus Bifidobacterium","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101456"}}